CH Biotech R&D Co., Ltd.

NT$85.50As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6534Materials
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (3.26%)
Div yield 6.21%
ROE 22.76%
Agricultural Inputs
Beta (5Y) 0.19
PE TTM 14.54
TSR TTM (12.87%)
Mkt cap NT$8.618B
ROIC 20.26%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$82
(3.58%)
(4.30%)
Hold 12|0|12|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.89
1.00
1.02
1.08
8.58%
8.80%
11.54%
17.31%
RevenueNT$M
822.5
816.6
832.7
850.9
10.49%
4.14%
4.42%
3.31%
Peers (US$260.3M)
Cap (US$)
PE
513.1M
15.42x
68.61M
25.97x
262.8M
—
Capital
TTM
5Y
10Y
Leveragex
2.732
0.111
0.107
EBIT/Intx
0.705
0.138
0.127
Own earn%
3.18
79.17
107.94
Sh yield%
49.15
34.47
34.16
Owners
Insiders/Inst%
2.29
37.71
Short interest%
5.45
SBC / revenue%
3.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
17–23
$1 testx
0.0
Incr. ROIC%
8